Viridian Therapeutics, Inc.\DE VRDN
NASDAQ VRDN
$22.82 -0.19 (-0.83%)
At close: Oct 22, 2026 · 4:00 PM EDT

Viridian Therapeutics, Inc.\DE (VRDN) Short term Debt (2024 - 2025)

Updated

Viridian Therapeutics, Inc.\DE's Short term Debt was $8.44 million in Q2 2025, up 184.6% from $2.96 million a year earlier.

Analysis

Viridian Therapeutics, Inc.\DE (VRDN) Short term Debt (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Viridian Therapeutics, Inc.\DE 2.39 Bn -714.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 8.44 Mn
Jun 30, 2024 2.96 Mn
API Access

Viridian Therapeutics, Inc.\DE Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=VRDN&period=max&api_key=YOUR_API_KEY